2-(Substituted-amino)-5-(pyridinyl-nicotinonitriles, and their c

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

546257, 546258, A61K 31455, A61K 3144, C07D21385

Patent

active

043627340

ABSTRACT:
Shown are cardiotonically active 2-RR'N-5-PY-6-Q-nicotinonitriles where R is methyl or ethyl, R' is hydrogen or methyl, PY is 4- or 3-pyridinyl or 4- or 3-pyridinyl having one or two substituents, and Q is hydrogen or methyl, the latter only when R' is hydrogen, or pharmaceutically acceptable acid-addition salts thereof. Also shown are cardiotonic compositions and a method for increasing cardiac contractility using as active components 2-RR'N-5-PY-6-Q-nicotinonitriles or pharmaceutically acceptable acid-addition salts thereof, where R, R', PY and Q are defined as above. Also shown is the process for preparing said 2-RR'N-5-PY-6-Q-nicotinonitriles by reacting a 2-halo-5-PY-6-Q-nicotinonitrile with an amine of the formula RR'NH.

REFERENCES:
patent: 4072746 (1978-02-01), Lesher et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2-(Substituted-amino)-5-(pyridinyl-nicotinonitriles, and their c does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2-(Substituted-amino)-5-(pyridinyl-nicotinonitriles, and their c, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2-(Substituted-amino)-5-(pyridinyl-nicotinonitriles, and their c will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1903171

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.